Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 1Myelodysplastic Syndromes 1Mycoses 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Genetic Predisposition to Disease 1Candidiasis 1Aspergillosis 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Fluconazole × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡